Why the study?
Does a pharmacy-managed, weight-based heparin protocol improve the achievement of therapeutic PTT goals compared to a fixed-dose protocol in patients receiving heparin?
Does a pharmacy-managed, weight-based heparin protocol improve the achievement of therapeutic PTT goals compared to a fixed-dose protocol in patients receiving heparin?
A pharmacy-managed, weight-based heparin protocol improves the rapidity and accuracy of achieving therapeutic anticoagulation goals compared to a physician-ordered fixed-dose protocol.
Answers are grounded in this paper and cite their sources.
May support faster heparin anticoagulation goals in pharmacy-managed settings; hypothesis-generating and should not yet change practice.
A revised protocol for heparin therapy, in which dosing was based on the patient's weight and the pharmacy staff assumed responsibility for management of the treatment protocol, was evaluated. A fixed-dose protocol for heparin therapy, in which an initial loading dose and infusion rate were specified by physicians and partial thromboplastin times (PTTs) were determined every 12 hours, was revised to determine dosing based on patient weight and diagnosis and to include more levels of dose adjustment and additional laboratory tests. Data on demographic characteristics of patients, heparin therapy, laboratory monitoring, conversion to warfarin therapy, and protocol management were collected for the patients receiving heparin under the revised protocol. Results were compared with those obtained for the old, fixed-dose protocol, which was managed by nursing staff. The revised protocol showed improvements in heparin therapy according to commonly accepted treatment criteria, including dosages, time to achieve a PTT associated with therapeutic anticoagulation, and the time a patient was in the target PTT range. The new protocol was also significantly more effective in avoiding low as well as high PTT ratios. The laboratory monitoring mandated by the revised protocol enhanced the monitoring of heparin therapy, and pharmacy management improved the accuracy and documentation of heparin therapy. Under the revised protocol, anticoagulation goals were attained more rapidly, and dosing changes were more likely to be correct and appropriately documented.
No takes yet. Share an insight, caveat, or question.
Rivey et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: